Medical Devices to Revolutionize with Integration of Cloud, IoT and AI
November 5, 2020 | PR NewswireEstimated reading time: 1 minute
Frost & Sullivan's recent analysis, Pipeline Analysis of Phase III Medical Therapeutic Devices: The Potential Game Changers and Growth Enablers, finds that the technology developmental trend for pipeline therapeutic medical devices in the late stage (Phase-III) of clinical development or clinical trial is shifting towards manufacturing portable, lightweight, and easy-to-use devices for patients, allowing their use in home settings. The integration of therapeutic medical devices with digital technologies aims to increase patient engagement and improve the treatment outcome for their disease condition, especially during and post the COVID-19 pandemic.
"Therapeutic medical devices delivering energy or electric fields non-invasively to the specific affected sites and eliminating systemic side effects can explore business opportunities in chronic diseases in oncology and neurology," said Ashish Kaul, Technical Insights Senior Research Analyst at Frost & Sullivan. "Going forward, advance manufacturing technology such as 3D printing can enable medtech companies to meet the market need in case of urgencies such as COVID-19 pandemic or high market demand for fast manufacturing."
Kaul added: "Medical device companies are exploring different biodegradable and recyclable plastic material to include it in its manufacturing process. Additionally, this use of biodegradable and recyclable materials in home-based therapeutic medical devices will increase significantly in the next five to six years."
The increasing permeation of therapeutic medical devices with digital technologies such as mobile applications presents immense growth prospects for market participants, including:
- Innovative non-invasive, lightweight, miniaturized, and portable medical devices can be developed using printed electronics components such as sensors and circuits.
- Needle-less and self-use medical devices can be developed to eliminate painful experiences during self-injection activities.
Therapeutic medical devices can be integrated with a cloud system, internet of things (IoT), and artificial intelligence (AI) so that the information collected by the devices can be analyzed and used for advanced research to understand complex diseases and develop effective treatments.
Suggested Items
GlobalFoundries Commits to Achieving Net Zero Emissions and Carbon-Neutral Power by 2050
04/23/2024 | GlobalFoundriesGlobalFoundries (GF) is furthering its commitment to sustainable operations and fighting climate change with the announcement of two new long-term goals to achieve net-zero greenhouse gas (GHG) emissions and 100% carbon-neutral power by 2050.
ROHM Group Company SiCrystal and STMicroelectronics Expand Silicon Carbide Wafer Supply Agreement
04/23/2024 | ROHMROHM and STMicroelectronics, a global semiconductor leader serving customers across the spectrum of electronics applications, announced today the expansion of the existing multi-year, long-term 150mm silicon carbide (SiC) substrate wafers supply agreement with SiCrystal, a ROHM group company.
IDTechEx Report Unveils 3D Electronics Status and Opportunities
04/22/2024 | PRNewswire3D electronics is an emerging manufacturing approach that enables electronics to be integrated within or onto the surface of objects. 3D electronic manufacturing techniques empower new features, including mass customizability, greater integration, and improved sustainability in the electronics industry.
Altus Group Helps BitBox Unlock Productivity and Efficiency Gains with New Reflow Oven
04/22/2024 | Altus GroupAltus Group, a leading provider of capital equipment, has recently assisted BitBox, a UK-based electronics design, engineering and manufacturing company in upgrading its operations with the implementation of a new reflow oven from Heller Industries.
Growth Potential: Electronics Manufacturing Driving Massive Surge in Manufacturing Investment
04/22/2024 | Shawn DuBravac, IPCIn the early months of the pandemic, investment in manufacturing infrastructure, such as plants and production facilities, declined sharply. Real investment dropped over 11%, before finally recovering to pre-pandemic levels in the first half of 2022. Over the past two years, however, several factors have combined to drive manufacturing investment to record levels.